PLYMOUTH MEETING, PA — Dr. Jacqueline Shea, President and CEO of INOVIO (NASDAQ: INO), a leading biotech firm, will be sharing her insights at the prestigious Oppenheimer 34th Annual Healthcare Life Sciences Conference. The event is set to take place on Wednesday, February 14, 2024, with Dr. Shea’s fireside chat scheduled for 12:40 PM ET.
The conference, renowned for hosting top-tier industry leaders, provides an opportunity for registered investors to engage in one-on-one meetings with INOVIO’s management team. These intimate discussions offer a unique platform to dive deeper into the company’s strategies, advancements, and future plans.
INOVIO, known for its innovation in DNA medicine, has been making significant strides in the biotech sector. The company’s presence at the conference underscores its commitment to transparency and open dialogue within the investment community.
Investors and interested parties unable to attend the conference can still partake in the conversation. A webcast of Dr. Shea’s presentation will be available on the INOVIO Investor Relations Events page. For those who miss the live webcast, a replay will remain available for 90 days following the presentation.
This conference appearance by Dr. Shea offers an exciting opportunity for investors and industry enthusiasts alike to gain firsthand insights into INOVIO’s direction and potential impact on the future of biotechnology.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.